Discussing the role of glucagonlike peptide-I.
Holst
J J
JJ
Orskov
C
C
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D005934:Glucagon / Q000032:analysis / Q000502:physiology*; D052216:Glucagon-Like Peptide 1; D004763:Glucagon-Like Peptides; D006801:Humans; D007328:Insulin / Q000502:physiology; D010446:Peptide Fragments / Q000032:analysis / Q000502:physiology* / Q000627:therapeutic use; D011498:Protein Precursors / Q000032:analysis / Q000502:physiology*
D007328:Insulin; D010446:Peptide Fragments; D011498:Protein Precursors; C061970:glucagon-like peptide 1 (7-36); D004763:Glucagon-Like Peptides; D052216:Glucagon-Like Peptide 1; D005934:Glucagon